Teva Pharmaceutical Industries reported $18.5B in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Aerie Pharmaceuticals AERI:US USD 312.59M 458K
ALKERMES ALKS:US USD 290.9M 633K
Amgen AMGN:US USD 37.16B 1.46B
AstraZeneca AZN:LN USD 23.68B 3.47B
Biogen BIIB:US USD 6.28B 1.8M
Bristol Myers Squibb BMY:US USD 36.97B 141M
Eli Lilly And LLY:US USD 14.14B 548.2M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Henry Schein HSIC:US USD 934M 165M
Horizon Pharma HZNP:US USD 2.55B 1.85M
JAZZ PHA JAZZ:US USD 5.7B 294.18M
Lannett LCI:US USD 619.34M 4.39M
Novartis NOVN:VX USD 21.24B 2.55B
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Patterson Companies PDCO:US USD 488.81M 255K
Perrigo Ordinary Shares PRGO:US USD 4.08B 8.6M
Revance Therapeutics RVNC:US USD 378.89M 506K
Takeda 4502:JP JPY 4.17T 151.94B
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B
Xeris Pharmaceuticals Inc XERS:US USD 138.51M 439K
Zoetis ZTS:US USD 5.21B 11M